FTC sues significant pharmacy reward managers over insulin prices The company brought motion from Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating tactics “artificially inflated” the listing price of lifestyle-saving insulin prescription drugs. Really don't overlook tomorrow's healthcare industry news Permit Healthcare Dive's cost-free ne... https://buschlightpeachnutritionf07529.blazingblog.com/30718656/details-fiction-and-healthcare-news